首页> 外文期刊>The International journal of periodontics & restorative dentistry >Treatment of Multiple Mandibular Gingival Recession Defects Using MCAT Technique and SCTG With and Without rhPDGF-BB: A Randomized Controlled Clinical Trial
【24h】

Treatment of Multiple Mandibular Gingival Recession Defects Using MCAT Technique and SCTG With and Without rhPDGF-BB: A Randomized Controlled Clinical Trial

机译:使用MCAT技术治疗多个下颌牙龈衰退缺陷,具有rhPDGF-BB的rhPDGF-BB:随机对照临床试验

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this randomized controlled trial was to compare the clinical outcomes of modified coronally advanced tunnel technique (MCAT) with subepithelial connective tissue graft (SCTG) with and without recombinant human platelet-derived growth factor-BB (rhPDGF-BB) for mandibular multiple recessions. Twenty-four Miller Class I and III recessions were randomly assigned to a group: test (MCAT+SCTG+rhPDGF-BB) or control (MCAT+SCTG). After 6 months, mean recession-depth reduction was higher in the test group (208 +/- 0.90 mm) than the control (1.83 +/- 0.93 mm). Mean root coverage was achieved, favoring the test group (82.6% +/- 23.69%) instead of the control (56.2% +/- 28.55%). Complete root coverage for the test group was 58.3%, which was significantly superior to control (16.7%). The use of rhPDGF-BB+SCTG using MCAT offered an advantage of a minimally invasive, predictable method for achieving optimal outcomes.
机译:这种随机对照试验的目的是将改性冠状动脉高级隧道技术(MCAT)与龈下结缔组织移植物(SCTG)进行了临床结果,其具有和没有重组人血小板衍生的生长因子-BB(RHPDGF-BB)的下颌多倍数 衰退。 将二十四级I和III次衰退进行随机分配给组:测试(MCAT + SCTG + RHPDGF-BB)或控制(MCAT + SCTG)。 6个月后,试验组(208 +/- 0.90 mm)的平均衰退减少比对照(1.83 +/- 0.93mm)更高。 达到平均根覆盖,最有利于试验组(82.6%+/- 23.69%)而不是对照(56.2%+/- 28.55%)。 测试组的完全根覆盖率为58.3%,可显着优于对照(16.7%)。 使用MCAT的使用RHPDGF-BB + SCTG提供了用于实现最佳结果的微创,可预测方法的优点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号